Mobile

A Multicenter, Randomized, Double-Blind, Parallel Arm, 12-Week Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin Combination Tablet Versus Atorvastatin in Elderly Patients With Hyperc...

Mise à jour : Il y a 4 ans
Référence : EUCTR2007-004448-60

A Multicenter, Randomized, Double-Blind, Parallel Arm, 12-Week Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin Combination Tablet Versus Atorvastatin in Elderly Patients With Hypercholesterolemia at Moderately High Risk and High Risk for CHD

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To assess the percent change from baseline in LDL-C levels after 12 weeks of treatment at the usual start dose comparisons of ezetimibe/simvastatin 10/20 mg versus atorvastatin 10 mg, and ezetimibe/simvastatin 10/20 mg versus atorvastatin 20 mg, and at the alternative start dose comparison of ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg.

Critère d'inclusion

  • Hypercholesterolemia

Liens